ConocoPhillips (FRA:YCP)

Blueprint Medicines Revenue

ConocoPhillips had revenue of $16.91B USD in the quarter ending March 31, 2025, with 18.50% growth. This brings the company's revenue in the last twelve months to $59.09B, up 4.00% year-over-year. In the year 2024, ConocoPhillips had annual revenue of $56.45B, down -2.44%.

• Revenue (ttm): $59.09B
• Revenue Growth: +4.00%
• P/S Ratio: 1.92
• Revenue / Employee: $5.01M
• Employees: 11,800
• Market Cap: 105.22B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	56.45B	-1.41B	-2.44%
Dec 31, 2023	57.86B	-22.71B	-28.19%
Dec 31, 2022	80.58B	33.92B	72.69%
Dec 31, 2021	46.66B	27.44B	142.82%
Dec 31, 2020	19.22B	-14.13B	-42.37%